Biomarkers of tumour redox status in response to modulations of glutathione and thioredoxin antioxidant pathways-Reference-Cited by-同舟云学术

Biomarkers of tumour redox status in response to modulations of glutathione and thioredoxin antioxidant pathways

Published:2018-01-31 Issue:2 Volume:52 Page:256-266
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Kengen Julie¹,Deglasse Jean-Philippe²,Neveu Marie-Aline¹,Mignion Lionel¹,Desmet Céline¹,Gourgue Florian¹,Jonas Jean-Christophe²,Gallez Bernard¹,Jordan Bénédicte F.¹

Affiliation:

1. Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Université Catholique de Louvain (UCL), Brussels, Belgium;

2. Institute of Experimental and Clinical Research, Pole of Endocrinology, Diabetes and Nutrition, Université Catholique de Louvain, Brussels, Belgium

Funder

Belgian National Fund for Scientific Research

Communauté Française de Belgique

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10715762.2018.1427236

Reference57 articles.

1. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate

2. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis